Published in J Bone Miner Metab on January 05, 2012
The role of Klotho in energy metabolism. Nat Rev Endocrinol (2012) 0.95
Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate. PLoS One (2013) 0.85
FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. Contrib Nephrol (2013) 0.83
Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity? Contrib Nephrol (2013) 0.77
Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity. Bonekey Rep (2015) 0.75
The role of phosphate in kidney disease. Nat Rev Nephrol (2016) 0.75
Effect of nickel on nutrient removal by selected indigenous protozoan species in wastewater systems. Saudi J Biol Sci (2014) 0.75
Survival-Related Autophagic Activity Versus Procalcific Death in Cultured Aortic Valve Interstitial Cells Treated With Critical Normophosphatemic-Like Phosphate Concentrations. J Histochem Cytochem (2017) 0.75
Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev (2005) 9.62
Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature (2006) 9.40
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet (2000) 7.41
Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem (2006) 6.50
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation (2005) 5.29
Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev (2005) 4.69
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet (2004) 3.42
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol (2004) 3.23
Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun (1998) 3.19
Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A (2007) 3.13
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J (2010) 2.91
Hypophosphatemia: an update on its etiology and treatment. Am J Med (2005) 2.85
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest (2007) 2.79
Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol (2008) 2.65
Inorganic phosphate treatment of hypercalcemia of diverse etiologies. N Engl J Med (1966) 2.46
Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology (2004) 2.40
Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase. Kidney Int (2009) 2.39
Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J (2008) 2.35
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. Am J Physiol Endocrinol Metab (2003) 2.31
The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol (2009) 2.26
Endocrine functions of bone in mineral metabolism regulation. J Clin Invest (2008) 2.19
In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. FASEB J (2008) 2.03
Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet (2006) 1.81
The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J Endocrinol (2007) 1.81
Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens (2006) 1.81
Fatal poisoning from sodium phosphate enema. Case report and experimental study. JAMA (1987) 1.71
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol (2009) 1.70
Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J (2010) 1.58
FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol (2008) 1.53
Hypophosphatemia. West J Med (1981) 1.53
FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player? Am J Physiol Renal Physiol (2008) 1.46
Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. Am J Physiol (1999) 1.44
Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol (2009) 1.39
Regulation of phosphorus homeostasis by the type iia na/phosphate cotransporter. Annu Rev Nutr (2005) 1.38
FGF-23, vitamin D and calcification: the unholy triad. Nephrol Dial Transplant (2005) 1.35
FGFR3 and FGFR4 do not mediate renal effects of FGF23. J Am Soc Nephrol (2008) 1.28
Fibroblast growth factor 23: roles in health and disease. J Am Soc Nephrol (2005) 1.27
In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels. Circ Cardiovasc Genet (2009) 1.26
Systematic review: adverse event reports for oral sodium phosphate and polyethylene glycol. Aliment Pharmacol Ther (2008) 1.25
Dietary phosphorus, calcium metabolism and bone. J Nutr (1993) 1.21
Common genetic variants associate with serum phosphorus concentration. J Am Soc Nephrol (2010) 1.20
Phosphate and FGF-23. Kidney Int Suppl (2011) 1.19
Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron (1997) 1.19
The collagen-specific molecular chaperone HSP47: is there a role in fibrosis? Trends Mol Med (2006) 1.18
New insights into the pathogenesis of inherited phosphate wasting disorders. Bone (1999) 1.17
Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol (2010) 1.16
Overview of the FGF23-Klotho axis. Pediatr Nephrol (2009) 1.15
Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial (2005) 1.14
Does FGF23 toxicity influence the outcome of chronic kidney disease? Nephrol Dial Transplant (2008) 1.12
Low calcium:phosphorus ratio in habitual diets affects serum parathyroid hormone concentration and calcium metabolism in healthy women with adequate calcium intake. Br J Nutr (2009) 1.12
Klotho: a fundamental regulator of aging. Ageing Res Rev (2002) 1.09
Phosphate toxicity: new insights into an old problem. Clin Sci (Lond) (2011) 1.09
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. J Bone Miner Metab (2011) 1.06
High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling. Am J Respir Crit Care Med (2008) 1.05
Structural and biochemical properties of fibroblast growth factor 23. Ther Apher Dial (2005) 1.03
Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc (2002) 1.03
Does renal ageing affect survival? Ageing Res Rev (2007) 1.01
Toward a better understanding of Klotho. Sci Aging Knowledge Environ (2006) 1.00
Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23. J Pathol (2008) 1.00
The dualistic role of vitamin D in vascular calcifications. Kidney Int (2010) 0.98
Injury by hypertonic phosphate enema. Can Med Assoc J (1977) 0.97
The kidney and bone metabolism: Nephrologists' point of view. J Bone Miner Metab (2006) 0.94
An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab (2009) 0.94
Osteo-renal regulation of systemic phosphate metabolism. IUBMB Life (2011) 0.94
Both FGF23 and extracellular phosphate activate Raf/MEK/ERK pathway via FGF receptors in HEK293 cells. J Cell Biochem (2010) 0.93
Disease model: human aging. Trends Mol Med (2001) 0.93
Severe hyperphosphatemia and hypocalcemia following the rectal administration of a phosphate-containing Fleet pediatric enema. Pediatr Emerg Care (2004) 0.90
Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372. Expert Opin Ther Pat (2010) 0.90
Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow. Clin Nephrol (2000) 0.90
Cellular/molecular control of renal Na/Pi-cotransport. Kidney Int Suppl (1998) 0.90
A 31P NMR study of mitochondrial inorganic phosphate visibility: effects of Ca2+, Mn2+, and the pH gradient. Biochemistry (1992) 0.89
The discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis. Cell Mol Life Sci (2008) 0.88
High dietary phosphate intake reduces bone strength in the growing rat skeleton. J Bone Miner Res (2007) 0.86
Molecular targets of hyperphosphataemia in chronic renal failure. Nephrol Dial Transplant (2003) 0.85
Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells. Acta Histochem Cytochem (2011) 0.84
Evaluation of hypophosphatemia: lessons from patients with genetic disorders. Am J Kidney Dis (2011) 0.83
Hyperphosphatemia. Clin Nephrol (1977) 0.83
Effects of prolonged high phosphorus diet on phosphorus and calcium balance in rats. J Clin Biochem Nutr (2007) 0.82
Renal risks of sodium phosphate tablets for colonoscopy preparation: a review of adverse drug reactions reported to the US Food and Drug Administration. Colorectal Dis (2011) 0.82
Genetic induction of phosphate toxicity significantly reduces the survival of hypercholesterolemic obese mice. Biochem Biophys Res Commun (2011) 0.82
Respiratory failure requiring extracorporeal membrane oxygenation after sodium phosphate enema intoxication. Eur J Pediatr (2003) 0.81
Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta. J Bone Miner Metab (2011) 0.80
Inorganic phosphate is transported into mitochondria in the absence of ATP biosynthesis: an in vivo 31P NMR study in the human skeletal muscle. Biochem Biophys Res Commun (1996) 0.79
Hyperphosphataemia and hypocalcaemia induced by hypertonic phosphate enema--an experimental study and review of the literature. Hum Exp Toxicol (1991) 0.79
FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets. J Bone Miner Metab (2011) 0.79
Hypophosphatemia. Am J Nurs (1985) 0.76
Rabbit model of primary hyperparathyroidism induced by high-phosphate diet. Domest Anim Endocrinol (2011) 0.76
Hyperphosphatemia. Endocr Pract (2010) 0.76
Vascular calcification in chronic kidney disease: new developments in drug therapy. Kidney Int (2007) 0.76
Hyperphosphatemia and its treatment. 1983. CANNT J (2008) 0.76
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol (2007) 3.73
Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol (2004) 3.23
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci U S A (2009) 2.23
Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci U S A (2007) 1.85
Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol (2006) 1.75
Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet (2008) 1.63
FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol (2008) 1.53
Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol (2005) 1.26
Biological activity of FGF-23 fragments. Pflugers Arch (2007) 1.03
Immunoinflammatory responses and fibrogenesis. Med Electron Microsc (2004) 0.98
Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands. Mol Cell Biol (2012) 0.96
Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor. J Biol Chem (2012) 0.96
Role of heat shock protein 47, a collagen-binding chaperone, in lacrimal gland pathology in patients with cGVHD. Invest Ophthalmol Vis Sci (2007) 0.93
Involvement of the fungal nuclear migration gene nudC human homolog in cell proliferation and mitotic spindle formation. Exp Cell Res (2002) 0.92
Inadequate awareness among chronic kidney disease patients regarding food and drinks containing artificially added phosphate. PLoS One (2013) 0.85
Lack of awareness among future medical professionals about the risk of consuming hidden phosphate-containing processed food and drinks. PLoS One (2011) 0.85
Heat shock protein 47: a novel biomarker of phenotypically altered collagen-producing cells. Acta Histochem Cytochem (2011) 0.84
Pathological influence of obesity on renal structural changes in chronic kidney disease. Clin Exp Nephrol (2009) 0.84
FGF23-induced hypophosphatemia persists in Hyp mice deficient in the WNT coreceptor Lrp6. Contrib Nephrol (2013) 0.83
PTHrP and tumorigenesis: is there a role in prognosis? Ann N Y Acad Sci (2007) 0.83
Oxidant stress in renal pathophysiology. Contrib Nephrol (2005) 0.79
Osteo-renal cross-talk and phosphate metabolism by the FGF23-Klotho system. Contrib Nephrol (2013) 0.78
Can salivary phosphate levels be an early biomarker to monitor the evolvement of obesity? Contrib Nephrol (2013) 0.77
Pathological significance of renal expression of NF-kappa B. Contrib Nephrol (2003) 0.77
Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system. Adv Chronic Kidney Dis (2011) 0.77
Role of heat shock protein 47 on tubulointerstitium in experimental radiation nephropathy. Pathol Int (2002) 0.76
Possible role of Ets-1 and MMP-1 in matrix remodeling in experimental cisplatin nephropathy. Med Electron Microsc (2002) 0.75
Interstitial expression of heat-shock protein 47 correlates with capillary deposition of complement split product C4d in chronic allograft nephropathy. Clin Transplant (2005) 0.75